Navigation Links
Pharma and Biotech Leaders to Converge in China at Asia Pharma R&D Leaders 2010 Summit

SHANGHAI, Dec. 2 /PRNewswire-Asia/ -- The world is going through extraordinary times; markets are in turmoil and uncertainty is part of many businesses and industries. It turns out that the pharma industry has been relatively immune to the economic downturn, because illness doesn't take a vacation.

During the midst of the difficult times this year, the pharmaceutical giant Johnson & Johnson inaugurated an R&D center in Shanghai, the largest of its kind in Asia. A similar plan was laid down by its biotech counterpart Genzyme, who invested USD90 million in Beijing to construct the company's first ever research facility in Asia.

What has made pharma and biotech companies invest heavily in Asia?

Find out the answer at Asia Pharma R&D Leaders 2010. As the time is drawing near for the event, the world's industry leaders will be under one roof to provide solutions and case studies in the challenging areas of drug research and development.

This year's meeting will aim to improve understanding of how the Asian pharmaceutical market is changing. Meet with key pharma industry leaders to discuss and learn from their own experiences and hear from real-life case studies on operational, regulatory, and strategic challenges of outsourcing drug discovery work to Asia. This event also provides excellent networking opportunities by way of a speed networking sessions where attendees will exchange details and make new contacts, as well as our contact system, which will allow participants to arrange meetings and email conference with attendees, speakers and the press.

    An updated list of this year's highlighted topics:
    -- Partnering for innovation in Asia, new collaboration opportunities with
       big pharma
       Laurent Bertin, Vice President, R&D External Innovation, Sanofi-Aventis
       Hans-Jochiam Bohm, Head of Global Chemistry, Hoffman La-Roche
       Daniel Grant, Head of Strategic Alliances, Pfizer Australia
       Pierre Desmons, Director, Head of Development Partnerships,
        GlaxoSmithKline Biologicals
    -- Regulatory updates in China and how the FDA is verifying the quality
       of outsourced work
       Christopher Hickey, Country Director (China), U.S. Food and Drug
    -- Successful stories of R&D operation management in Asia and Do's &
       Don'ts in outsourcing
       Steve Yang, Head of Research Asia Global R&D, Pfizer
       Lily Lee, Senior Vice President and Head of Pharmaceutical R&D Asia,
        Johnson & Johnson
       Li Chen, Chief Scientific Officer Roche R&D China, Roche
       Tony Zhang, Managing Director and Site Head of China, Eli Lilly Global
       Canwen Jiang, Head of R&D Asia, Genzyme Corporation
       Kim Andersen, Vice President R&D, Lundbeck AS
       Samantha Du, CEO, Hutchison MediPharma
       Richard Wang, Director, Strategic Alliance and Collaboration for Asia,
       Yoshiki Nishikawa, Director of Kobe Pharma Research Institute Nippon,
        Boehringer Ingelheim

Plus, the event sets up an effective platform for attendees to meet face to face with a variety of Asia's local CROs and leading clinical practitioners to discuss the specifics of outsourcing requirements.

An international audience consisting of senior-level pharma and biotech executives from the R&D, clinical development, business development, global market access, licensing, and regulatory affairs functions will be in attendance. For the full program and list of companies scheduled to attend, please visit the event website at

    For more information on registration and sponsoring/exhibiting, please

     Daniel Chen
     Global Leaders Institute
     Phone: +86-21-3251-6046

SOURCE Global Leaders Institute

SOURCE Global Leaders Institute
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. PDL BioPharma Provides Fourth Quarter 2009 Revenue Guidance of Approximately $57 Million
2. Tepnel Pharmaceutical Services to Offer DNA Genotek's Sample Collection Kit in its Nucleic Acid Extraction and Genotyping Service
3. Another Top Five Pharmaceutical Company Selects iCardiac as Preferred Provider of ECG Core Lab Services
4. Kiadis Pharma Announces Enrollment of First Patients in a Multinational Registration Study for ATIR(TM)
5. China Yongxin Pharmaceuticals Inc. to Distribute Medicines on the Essential Drug List
6. WuXi PharmaTech Named in Deloitte Technology Fast 50 China 2009 List for the Fifth Consecutive Year
7. Sepha's Blue Dye Test Alternative Brings ‘Complete Automation' To Pharma-Packaging Quality Assurance
8. KTA Capital Arranges an AU$6.7 Million Private Placement by Neuren Pharmaceuticals
9. Arena Pharmaceuticals to Present at the Piper Jaffray 21st Annual Health Care Conference
10. PDL BioPharma Announces Ex-Dividend Date of November 27 for Special Dividend
11. NeoStem Outlines to Shareholders Near-term and Long-term Business Strategies Following Acquisition of Chinese Pharmaceutical Company
Post Your Comments:
(Date:11/24/2015)... , Nov. 24, 2015 /PRNewswire/ - Aeterna Zentaris Inc. ... IIROC on behalf of the Toronto Stock Exchange, confirms ... there are no corporate developments that would cause the ... --> --> About Aeterna Zentaris ... . --> Aeterna Zentaris is a specialty ...
(Date:11/24/2015)... , ... November 24, 2015 , ... The Academy of ... Interest Group (SIG), MultiGP, also known as Multirotor Grand Prix, to represent the First–Person ... few years. Many AMA members have embraced this type of racing and several new ...
(Date:11/24/2015)... 2015 /PRNewswire/ - Aeterna Zentaris Inc. (NASDAQ:  AEZS) ... remaining 11,000 post-share consolidation (or 1,100,000 pre-share consolidation) ... B Warrants") subject to the previously disclosed November ... 2015, which will result in the issuance of ... the issuance of such shares, there will be ...
(Date:11/24/2015)... ... November 24, 2015 , ... Creation Technologies ... being named to Deloitte's 2015 Technology Fast 500 list of the fastest growing ... a FDA-cleared, Class II medical device that speeds up orthodontic tooth movement by ...
Breaking Biology Technology:
(Date:10/29/2015)... Mich. , Oct. 29, 2015  Rubicon ... Genomics for U.S. distribution of its DNA library ... kit and Rubicon,s new ThruPLEX Plasma-seq kit. ThruPLEX ... enable the preparation of NGS libraries for liquid ... for diagnostic and prognostic applications in cancer and ...
(Date:10/27/2015)... 27, 2015 In the present market scenario, ... for various industry verticals such as banking, healthcare, defense, ... growing demand for secure & simplified access control and ... as hacking of bank accounts, misuse of users, , ... as PC,s, laptops, and smartphones are expected to provide ...
(Date:10/26/2015)... PALO ALTO, Calif. and LAS ... – Nok Nok Labs , an innovator in ... FIDO Alliance , today announced the launch of its ... the first unified platform enabling organizations to use standards-based ... authentication. The Nok Nok S3 Authentication Suite is ideal ...
Breaking Biology News(10 mins):